News

Alpha Teknova will announce Q1 2025 financial results on May 8, including a webcast at 5 p.m. ET.

Quiver AI Summary

Alpha Teknova, Inc. will release its financial results for the first quarter of 2025 on May 8, 2025, after market close. The company will also host a webcast and conference call that same day at 5 p.m. Eastern Time, which can be accessed through their Investor Relations page. Participants are encouraged to register in advance for the event, which will also be available for replay on Teknova's website. Teknova is known for producing critical reagents that support the life sciences industry, helping accelerate the development of therapies and diagnostics since 1996. The company is headquartered in Hollister, California, and offers customizable solutions to aid various stages of scientific workflows.

Potential Positives

• Announcement of upcoming financial results for Q1 2025 indicates transparency and regular communication with investors.
• Hosting a webcast and conference call for investors highlights the company's commitment to engaging with its stakeholders.
• The emphasis on Teknova's innovative capabilities in producing critical reagents positions the company as a leader in the life sciences sector, potentially attracting interest from investors and partners.

Potential Negatives

• Announcing financial results on May 8, 2025, suggests that the company may be delayed in providing information about its first quarter performance, potentially raising concerns among investors about its financial health.
• The focus solely on the date of the financial report and upcoming conference call may imply a lack of significant immediate achievements or updates that the company can share at this time, which could be seen as a negative indicator of its current operations.
• There is no mention of any financial expectations or guidance for future performance, which may leave investors feeling uncertain about the company's trajectory.

FAQ

When will Alpha Teknova report its financial results?

Alpha Teknova will report its financial results for Q1 2025 on May 8, 2025.

How can I access the Teknova conference call?

You can access the conference call by visiting the Investor Relations section of the Teknova website or using a provided link.

What time is the Teknova webcast scheduled?

The Teknova webcast is scheduled for 5 p.m. Eastern Time on May 8, 2025.

Will the Teknova webcast be available for replay?

Yes, the webcast will be available for replay on the Teknova website approximately two hours after the event.

What is Teknova known for?

Teknova is known for producing critical reagents for therapies, vaccines, and molecular diagnostics since 1996.

Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.

$TKNO Hedge Fund Activity

We have seen 29 institutional investors add shares of $TKNO stock to their portfolio, and 18 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS GROUP AG added 1,112,745 shares (+246728.4%) to their portfolio in Q4 2024, for an estimated $9,291,420
• INVESCO LTD. added 1,106,161 shares (+inf%) to their portfolio in Q4 2024, for an estimated $9,236,444
• MILLENNIUM MANAGEMENT LLC removed 737,215 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $6,155,745
• SCHONFELD STRATEGIC ADVISORS LLC removed 344,207 shares (-93.9%) from their portfolio in Q4 2024, for an estimated $2,874,128
• POINT72 ASSET MANAGEMENT, L.P. removed 306,427 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $2,558,665
• PARKMAN HEALTHCARE PARTNERS LLC removed 251,026 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $2,096,067
• ROUBAIX CAPITAL, LLC removed 211,707 shares (-50.8%) from their portfolio in Q4 2024, for an estimated $1,767,753

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Full Release

HOLLISTER, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the first quarter ended March 31, 2025, on Thursday, May 8, 2025, following the close of market.

Teknova will host a webcast and conference call on Thursday, May 8, 2025, beginning at 5 p.m. Eastern Time. To access the live webcast, listeners can log onto the call from the
Investor Relations
section of the Teknova website or by using this
link
. If you would like to participate in the call, please register for the webcast
here
to receive a unique PIN number and dial-in information. The webcast will be available for replay on the Company’s website approximately two hours after the event.

About Teknova

Teknova makes solutions possible. Since 1996, Teknova has been innovating the manufacture of critical reagents for the life sciences industry to accelerate the discovery and development of novel breakthroughs that will help people live longer, healthier lives. We offer fully customizable solutions for every stage of the workflow, supporting industry leaders in molecular diagnostics, synthetic biology, and emerging therapeutic modalities. Our fast turnaround of high-quality agar plates, microbial culture media, buffers and reagents, and water helps our customers scale seamlessly from RUO to GMP. Headquartered in Hollister, California, with over 180,000 square feet of state-of-the-art facilities, Teknova’s modular manufacturing platform was designed by our team of scientists, engineers, and quality control experts to efficiently produce the foundational ingredients for the discovery and commercialization of next-generation therapies.

Investor Contact

Matt Lowell

Chief Financial Officer

matt.lowell@teknova.com

+1 831-637-1100

Media Contact

Jennifer Henry

Senior Vice President, Marketing

jenn.henry@teknova.com

+1 831-313-1259

This press release was published by a CLEAR® Verified individual.

This article was originally published on Quiver News, read the full story.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.